Company intelligence / Profile preview

Vaxa Technologies

Reykjavík (Facility near Hellisheiði geothermal plant, Contact address also listed as Árleynir 8–112 Reykjavík), Icelandvxa.se ↗

Ownership: Private
Development stage: Other

Overview

Vaxa Technologies has developed an automated indoor cultivation process for microalgae—primarily spirulina—using geothermal energy. Their products are rich in Omega‑3s, protein, iron, and vitamin B12. The company’s approach uses less than 1% of the land/freshwater required by traditional agriculture while achieving 10x yield. Products are used both as sustainable human nutrition supplements and aquaculture feed that improves fish survival rates.

Therapeutic areas: Metabolic DisordersOther
Modalities: Microbial therapyProtein
Industry: Non-Drug Biotech

Partnerships

Siemens (automation technology partner)DIC Corporation (strategic investor/collaborator)

Beyond the preview

Go deeper on Vaxa Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaxa Technologies.

Explore the full profile